My-La CD8+

Кат. номер

95051033-CDNA-20UL

95051033-RNA-5UG

95051033-DNA-5UG

95051033-1VL

Human Caucasian T Lymphocyte, mycosis fungoides.
The cell line My-La, CD8+, also known as My-La, marker chromosome was established from a plaque biopsy of an 82 year old Caucasian patient with mycosis fungoides stage II. Together with My-La, CD8+ a second cell line has been established (My-La, CD4+ Sigma Catalogue number. 95051032) by including IL-2 and IL-4 in the culture medium. My-La, CD8+ shows characteristic chromosome markers, express -13 of the T-cell receptor and are double homozygous for HLA-A1.B8. Phenotypically a weak staining was observed for CD2, CD3, CD8, CD25, CD71 and TCR-1 α / . There has been no evidence of HTLV-I infection in the cell line and serum from the patient did not demonstrate antibodies against HTLV-I and HTLV-II. My-La, CD8+ cells show a low viability after resuscitation from frozen and a long lag time phase until exponential growth is reached.
Study of antigen-independent proliferation of T- cell lyphoma from mycosis fungoides patient.
RPMI 1640 + 2mM Glutamine + 100 u/ml IL-2 + 10% human AB seum
Maintain cultures between 3-9 x 100,000 cells/ml; 5% CO2; 37°C. Split only 1:2 as maximum dilution: freeze in growth medium plus 10% DMSO, low viability on resuscitation. Use of human serum produces high levels of debris in cultures.
Additional freight & handling charges may be applicable for Asia-Pacific shipments. Please check with your local Customer Service representative for more information.

biological source	human lymph
growth mode	Suspension
karyotype	Not specified
morphology	Lymphoblastoid
products	Not specified
receptors	Not specified
application(s)	cell culture | mammalian: suitable
relevant disease(s)	cancer
shipped in	dry ice
storage temp.	−196°C

RIDADR	NONH for all modes of transport
WGK Germany	3